FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

422456007: Ranibizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2007. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2641602015 Ranibizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2645708017 Ranibizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranibizumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Ranibizumab Is a Substance with angiogenesis inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Ranibizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Ranibizumab Has disposition Angiogenesis inhibitor true Inferred relationship Existential restriction modifier
Ranibizumab Has disposition Vascular endothelial growth factor receptor antagonist true Inferred relationship Existential restriction modifier
Ranibizumab Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ranibizumab Has active ingredient True Ranibizumab Inferred relationship Existential restriction modifier 1
Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial Has active ingredient False Ranibizumab Inferred relationship Existential restriction modifier
Uveitis caused by ranibizumab Causative agent False Ranibizumab Inferred relationship Existential restriction modifier 2
Ranibizumab Has active ingredient True Ranibizumab Inferred relationship Existential restriction modifier 1
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Ranibizumab Inferred relationship Existential restriction modifier 1
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Ranibizumab Inferred relationship Existential restriction modifier 1
Product containing ranibizumab in parenteral dose form (medicinal product form) Has active ingredient True Ranibizumab Inferred relationship Existential restriction modifier 1
Product containing only ranibizumab in parenteral dose form (medicinal product form) Has active ingredient True Ranibizumab Inferred relationship Existential restriction modifier 1
Uveitis caused by ranibizumab Causative agent True Ranibizumab Inferred relationship Existential restriction modifier 1
Ongavia 2.3mg/0.23ml solution for injection vials (Teva UK Ltd) 1 vial Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Ongavia 2.3mg/0.23ml solution for injection vials (Teva UK Ltd) Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Ranibizumab 3mg/0.3ml solution for injection vials Has active ingredient False Ranibizumab Inferred relationship Existential restriction modifier
Lucentis 3mg/0.3ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Ranibizumab 3mg/0.3ml solution for injection vials 1 vial Has active ingredient False Ranibizumab Inferred relationship Existential restriction modifier
Lucentis 3mg/0.3ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Ranibizumab Inferred relationship Existential restriction modifier
Byooviz 2.3mg/0.23ml solution for injection vials (Biogen Idec Ltd) 1 vial Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Byooviz 2.3mg/0.23ml solution for injection vials (Biogen Idec Ltd) Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Ranibizumab 2.3mg/0.23ml solution for inection vials Has active ingredient False Ranibizumab Inferred relationship Existential restriction modifier
Lucentis 2.3mg/0.23ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Ranibizumab 2.3mg/0.23ml solution for inection vials 1 vial Has active ingredient False Ranibizumab Inferred relationship Existential restriction modifier
Lucentis 2.3mg/0.23ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Ranibizumab Inferred relationship Existential restriction modifier
Lucentis 3mg/0.3ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Ranibizumab 3mg/0.3ml solution for injection vials 1 vial Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Ranibizumab 3mg/0.3ml solution for injection vials Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Lucentis 3mg/0.3ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Ranibizumab 2.3mg/0.23ml solution for inection vials Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Lucentis 2.3mg/0.23ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Lucentis 2.3mg/0.23ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Ranibizumab 2.3mg/0.23ml solution for inection vials 1 vial Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes Has active ingredient False Ranibizumab Inferred relationship Existential restriction modifier
Ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Lucentis 1.65mg/0.165ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Lucentis 1.65mg/0.165ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier
Lucentis 1.65mg/0.165ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Ranibizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start